NFKB1 and colitis: Xiong et al. (Xiong et al., 2021) reported that berberine could inhibit M1 polarization and promote M2 polarization in colonic macrophages, improve the intestinal inflammatory environment, and relieve colitis by inhibiting the NF-κB signaling pathway.